{"podcast":{"title":"Business News Today | 2 Min News | The Daily News Now!","slug":"business-finance-news-today-2-min-news-the-daily-news-now-7726192","podcast_index_feed_id":7726192,"rss_url":"https://feeds.fastcast.ai/the-daily-news-now-business.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/cover/a77b5c94-431e-4490-8653-1f676f1da586.png","author":"The Daily News Now!","episode_count":2000,"summary":"Hosted by Corey with the Story, Business News Today is your daily source for the latest headlines and stories shaping the world of business, finance, and the global economy. From market trends and corporate earnings to startups, entrepreneurship, technology, real estate, consumer trends, and economic policy, we bring you the business news that matters most—in just a few minutes. Whether you're an entrepreneur, investor, executive, business owner, or simply someone who wants to stay informed, Business News Today delivers clear, concise updates to help you understand the forces shaping the economy and the future of business. Business News Today — Business news, all in one place. Powered by AI.","last_synced_at":"2026-09-17T06:21:31.382927+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192"},"episode":{"title":"Pfizer's Dividend Play for Generational Wealth","slug":"pfizer-s-dividend-play-for-generational-wealth","published_at":"2026-06-22T02:09:57+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/pfizer-s-dividend-play-for-generational-wealth","show_page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192","url":"https://api.fastcast.ai/audio/0750641c-4590-4384-bbb7-05351892bdc7.mp3","audio_url":"https://api.fastcast.ai/audio/0750641c-4590-4384-bbb7-05351892bdc7.mp3","summary":"Pfizer’s stock has plunged 50% from its 2021 peak, boosting its dividend yield to a juicy 6.8%—a rare gem for drugmakers. While investors fret over looming patent expirations that’ll slash revenue from blockbuster drugs, the company’s long-term resilience shines. New drug pipelines are lagging, and the payout ratio’s already over 100%, but management’s committed to the dividend. This is a classic turnaround play: short-term pain, long-term gain. Even if the dividend dips, the yield remains attractive, and the stock could deliver generational wealth for patient investors who believe in Pfizer’s history of bouncing back. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/c14ef8a0159dc9c6","meta_description":"Pfizer’s stock has plunged 50% from its 2021 peak, boosting its dividend yield to a juicy 6.8%—a rare gem for drugmakers. While investors fret over loomin…","key_points":[],"chapters":[],"topics":[],"duration_seconds":114,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/pfizer-s-dividend-play-for-generational-wealth/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/pfizer-s-dividend-play-for-generational-wealth.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}